TY - JOUR
T1 - Cutting Edge
T2 - The Tetraspanin CD53 Promotes CXCR4 Signaling and Bone Marrow Homing in B Cells
AU - Chakraborty, Mousumi
AU - Greenberg, Zev J.
AU - Dong, Qian
AU - Roundy, Nate
AU - Bednarski, Jeffrey J.
AU - Paracatu, Luana Chiquetto
AU - Duncavage, Eric
AU - Li, Weikai
AU - Schuettpelz, Laura G.
N1 - Publisher Copyright:
Copyright © 2024 by The American Association of Immunologists, Inc. 0022-1767/24/$37.50.
PY - 2024/4/1
Y1 - 2024/4/1
N2 - B cell trafficking involves the coordinated activity of multiple adhesive and cytokine-receptor interactions, and the players in this process are not fully understood. In this study, we identified the tetraspanin CD53 as a critical regulator of both normal and malignant B cell trafficking. CXCL12 is a key chemokine in B cell homing to the bone marrow and secondary lymphoid organs, and both normal and malignant B cells from Cd532/2 mice have reduced migration toward CXCL12 in vitro, as well as impaired marrow homing in vivo. Using proximity ligation studies, we identified the CXCL12 receptor, CXCR4, as a novel, to our knowledge, CD53 binding partner. This interaction promotes receptor function, because Cd532/2 B cells display reduced signaling and internalization of CXCR4 in response to CXCL12. Together, our data suggest that CD53 interacts with CXCR4 on both normal and malignant B cells to promote CXCL12 signaling, receptor internalization, and marrow homing. The Journal of Immunology, 2024, 212: 1075-1080.
AB - B cell trafficking involves the coordinated activity of multiple adhesive and cytokine-receptor interactions, and the players in this process are not fully understood. In this study, we identified the tetraspanin CD53 as a critical regulator of both normal and malignant B cell trafficking. CXCL12 is a key chemokine in B cell homing to the bone marrow and secondary lymphoid organs, and both normal and malignant B cells from Cd532/2 mice have reduced migration toward CXCL12 in vitro, as well as impaired marrow homing in vivo. Using proximity ligation studies, we identified the CXCL12 receptor, CXCR4, as a novel, to our knowledge, CD53 binding partner. This interaction promotes receptor function, because Cd532/2 B cells display reduced signaling and internalization of CXCR4 in response to CXCL12. Together, our data suggest that CD53 interacts with CXCR4 on both normal and malignant B cells to promote CXCL12 signaling, receptor internalization, and marrow homing. The Journal of Immunology, 2024, 212: 1075-1080.
UR - http://www.scopus.com/inward/record.url?scp=85188479873&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.2300336
DO - 10.4049/jimmunol.2300336
M3 - Article
C2 - 38363205
AN - SCOPUS:85188479873
SN - 0022-1767
VL - 212
SP - 1075
EP - 1080
JO - Journal of Immunology
JF - Journal of Immunology
IS - 7
ER -